Search Results

National study on biphosphonate-induced osteonecrosis of the jaw

Source: Oral Surgery, Volume 2, Number 2, May 2009 , pp. 55-55(1)

Publisher: Blackwell Publishing

Bisphosphonate bei malignen Knochentumoren

Author: Holzer, G.

Source: Der Orthopäde, Volume 38, Number 4, April 2009 , pp. 316-323(8)

Publisher: Springer

Chemotherapie beim Prostatakarzinom

Authors: Rauchenwald, Michael; De Santis, Maria; Fink, Eleonore; Höltl, Wolfgang; Kramer, Gero; Marei, Isabella-Carolina; Neumann, Hans-Jörg; Reissigl, Andreas; Schmeller, Nikolaus; Stackl, Walter; Hobisch, Alfred; Krainer, Michael

Source: Wiener klinische Wochenschrift, Volume 120, Numbers 13-14, July 2008 , pp. 440-449(10)

Publisher: Springer

Periodontal Diseases and Rheumatoid Arthritis: A Coincident Model for Therapeutic Intervention?

Author: Soory, Mena

Source: Current Drug Metabolism, Volume 8, Number 8, December 2007 , pp. 750-757(8)

Publisher: Bentham Science Publishers

Screening for bone health in epilepsy

Authors: Sheth, Raj D.; Harden, Cynthia L.

Source: Epilepsia, Volume 48, Supplement 9, December 2007 , pp. 39-41(3)

Publisher: Blackwell Publishing

Pulmonary function tests in an infant with osteogenesis imperfecta and early biphosphonate treatment

Authors: Rugolotto, S; Monti, E; Carli, M; Pietrobelli, A; Antoniazzi, F; Tato', L

Source: Acta Pædiatrica, Volume 96, Number 12, December 2007 , pp. 1856-1857(2)

Publisher: Blackwell Publishing

Effect of kidney transplantation on bone

Authors: Kodras, K.; Haas, M.

Source: European Journal of Clinical Investigation, Volume 36, Supplement 2, August 2006 , pp. 63-75(13)

Publisher: Blackwell Publishing

Clodronate treatment of vitamin D-induced hypercalcemia in dogs

Authors: Ulutas, Bulent; Voyvoda, Huseyin; Pasa, Serdar; Alingan, Mustafa Kemal

Source: Journal of Veterinary Emergency and Critical Care, Volume 16, Number 2, June 2006 , pp. 141-145(5)

Publisher: Blackwell Publishing

A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma

Authors: Lewis, Karl; Thompson, John; Weber, Jeffrey; Robinson, William; O'Day, Steven; Lutzky, Jose; Legha, Sewa; Floret, Simon; Ruvuna, Francis; Gonzalez, Rene

Source: Investigational New Drugs, Volume 24, Number 1, January 2006 , pp. 89-94(6)

Publisher: Springer

Biphosphonate-induced radiographic changes in two pediatric patients with rheumatic diseases

Authors: Fernandes, Joao; Viana, Sergio; Rocha, Arthemizio; Ribeiro, Maria; Castro, Luis

Source: Skeletal Radiology, Volume 33, Number 12, December 2004 , pp. 732-736(5)

Publisher: Springer

Long-term control of hypercalcaemia in an infant with Williams-Beuren syndrome after a single infusion of biphosphonate (Pamidronate)

Authors: B Oliveri; SR Mastaglia; C Mautalen; JC Gravano; L Pardo Argerich

Source: Acta Paediatrica, Volume 93, Number 7, July 2004 , pp. 1002-1003(2)

Publisher: Informa Healthcare

Alendronate for treatment of renal transplant patients with osteoporosis

Authors: Torregrosa J.V.; Moreno A.; Gutierrez A.; Vidal S.; Oppenheimer F.

Source: Transplantation Proceedings, Volume 35, Number 4, June 2003 , pp. 1393-1395(3)

Publisher: Elsevier

Effect of pamidronate on the stimulation of macrophage TNF- release by ultra-high-molecular-weight polyethylene particles: a role for apoptosis

Authors: Huk O.L.; Zukor D.J.; Antoniou J.; Petit A.

Source: Journal of Orthopaedic Research, Volume 21, Number 1, 2003 , pp. 81-87(7)

Publisher: Elsevier

Biphosphonates in children: present and future.

Authors: Kone Paut I.; Gennari J.M.; Retornaz K.; Jouve J.L.; Bollini G.

Source: Archives de Pediatrie, Volume 9, Number 8, August 2002 , pp. 836-842(7)

Publisher: Elsevier

Development and validation of a highly sensitive RIA for zoledronic acid, a new potent heterocyclic bisphosphonate, in human serum, plasma and urine

Authors: Legay F.; Gauron S.; Deckert F.; Gosset G.; Pfaar U.; Ravera C.; Wiegand H.; Schran H.

Source: Journal of Pharmaceutical and Biomedical Analysis, Volume 30, Number 4, 7 November 2002 , pp. 897-911(15)

Publisher: Elsevier

Parathyroid hormone-related peptide in pancreatic neuroendocrine tumours associated with hypercalcaemia

Authors: Papazachariou IM; Virlos IT; Williamson RCN

Source: Hpb, Volume 3, Number 3, 1 September 2001 , pp. 221-225(5)

Publisher: Taylor and Francis Ltd

Osteogenesis imperfecta: a new therapeutic approach with biphosphonates. A case report.

Authors: Guillot M.; Eckart P.; Desrosieres H.; Amiour M.; Al-Jazayri Z.

Source: Archives de Pediatrie, Volume 8, Number 2, February 2001 , pp. 172-175(4)

Publisher: Elsevier

Bone-specific delivery and sustained release of diclofenac, a non-steroidal anti-inflammatory drug, via bisphosphonic prodrug based on the Osteotropic Drug Delivery System (ODDS)

Authors: Hirabayashi H.; Takahashi T.; Fujisaki J.; Masunaga T.; Sato S.; Hiroi J.; Tokunaga Y.; Kimura S.; Hata T.

Source: Journal of Controlled Release, Volume 70, Number 1, 29 January 2001 , pp. 183-191(9)

Publisher: Elsevier

Effet antalgique d'une perfusion de bisphosphonates a la phase aigued'un tassement vertebral osteoporotiquechez le sujet age

Authors: Godfrin B.; Alvarez M.; Laroche M.; Ollier S.; Dingremont C.; Sailler L.; Arlet P.

Source: La Revue de Medecine Interne, Volume 21, Number 11, November 2000 , pp. 1004-1005(2)

Publisher: Elsevier

The serum Crosslaps, comparison with the results of urinary Crosslaps during treatment with bisphosphonates.

Authors: Hoffmann J.-P.; Hoffmann A.; Weber L.

Source: Immunoanalyse & Biologie Specialisee, Volume 14, Number 5, September 1999 , pp. 354-358(5)

Publisher: Elsevier